Last update :
19/11/2024
Anticancer drug   Blinatumomab  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Blincyto Argentina, Australia, Austria, Belgium, Brazil, Chile, Denmark, France, Germany, Great Britain, Hungary, Ireland, Italy, Japan, Luxembourg, Mexico, Norway, Peru, Romania, Slovenia, Spain, Sweden, Switzerland, United States of America
Stability in solutions   injection   Stability in solutions : Blinatumomab     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Water for Injection 12,5 µg/ml 2-8°C Protect from light
24 Hour
3774
Manufacturer's stability data

Glass Water for Injection 12,5 µg/ml 23-27°C Protect from light
4 Hour
3774
Manufacturer's stability data

Polyolefine Sodium chloride 0,9% 0,26 µg/ml 2-8°C Not specified
10 Day
3774
Manufacturer's stability data

Polyolefine Sodium chloride 0,9% 0,26 µg/ml 23-27°C Not specified
96 Hour
3774
Manufacturer's stability data

Ethylene vinyl acetate Sodium chloride 0,9% 0,26 µg/ml 2-8°C Not specified
10 Day
3774
Manufacturer's stability data

Ethylene vinyl acetate Sodium chloride 0,9% 0,26 µg/ml 23-27°C Not specified
96 Hour
3774
Manufacturer's stability data


  Mentions Légales